These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6608812)

  • 1. Linked help in the cytotoxic T-cell response revealed by adoptive transfer.
    Mitchison NA
    Transplant Proc; 1983 Dec; 15(4):2121-4. PubMed ID: 6608812
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural changes in class I MHC molecules influencing recognition by allo- or self + TNP-reactive cytotoxic T-cell clones and by monoclonal antibodies.
    Davignon JL; Albert F; Boyer C; Hua C; Buferne M; Guimezanes A; Schmitt-Verhulst AM
    Transplant Proc; 1983 Dec; 15(4):2080-5. PubMed ID: 6608811
    [No Abstract]   [Full Text] [Related]  

  • 3. Specificity and regulation of cytotoxic T-lymphocyte responses analyzed with H-2 mutants.
    Melief CJ; Stukart MJ; de Waal LP; Kast WM; Melvold RW
    Transplant Proc; 1983 Dec; 15(4):2086-9. PubMed ID: 6324427
    [No Abstract]   [Full Text] [Related]  

  • 4. Target sites for antibodies and cytotoxic T lymphocytes on H-2 molecules.
    Rüsch E; Kuon W; Hämmerling GJ
    Transplant Proc; 1983 Dec; 15(4):2093-6. PubMed ID: 6200977
    [No Abstract]   [Full Text] [Related]  

  • 5. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further molecular and functional evidence for the expression of H-2 allodeterminants on the AKR leukemia, K36.
    Festenstein H; Alonzo AD; Ferluga J; Ma BL; Santamaria M; Marelli O; Schmidt W; Flavell RA
    Transplant Proc; 1983 Dec; 15(4):2107-10. PubMed ID: 6200978
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense.
    Messaoudi I; Guevara Patiño JA; Dyall R; LeMaoult J; Nikolich-Zugich J
    Science; 2002 Nov; 298(5599):1797-800. PubMed ID: 12459592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the B6.C-H-2bm-1 (H-2bm-1) cytotoxic T lymphocyte clonal response to EL4.
    Saunders PH; Lawlor DA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):878-9. PubMed ID: 3274883
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells.
    Apasov SG; Sitkovsky MV
    J Immunol; 1994 Mar; 152(5):2087-97. PubMed ID: 8133027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raising allo-restricted cytotoxic T lymphocytes by co-culture of murine splenocytes with autologous macrophage bearing the peptide/allo-major histococompatibility complex.
    Chen X; Yan Y; Lu S; Weng X; Liang Z; Li J; Zhong M; Tang J; Xiao W; Sun W; Shen G; Wu X
    Hum Immunol; 2009 Feb; 70(2):79-84. PubMed ID: 19100802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-MHC-linked genetic control of murine cytotoxic T lymphocyte responses to hapten-modified syngeneic cells.
    Arora PK; Shearer GM
    J Immunol; 1981 Nov; 127(5):1822-8. PubMed ID: 6975299
    [No Abstract]   [Full Text] [Related]  

  • 13. Manifestation of the MHC-unrestricted killing potential of a cytotoxic T cell clone requires activation in response to MHC-restricted self-presentation of antigen.
    Dick T; Staege MS; Reichmann G; Reske-Kunz AB
    J Immunol; 1993 Apr; 150(7):2575-83. PubMed ID: 8454844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies.
    Rosenstein M; Rosenberg SA
    J Natl Cancer Inst; 1984 May; 72(5):1161-5. PubMed ID: 6609266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype.
    Sabapathy TK; Cheng Q; Hui KM
    Cell Immunol; 1995 Nov; 166(1):141-53. PubMed ID: 7585974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of respiratory syncytial virus-specific cytotoxic T-cell responses following immunization with a synthetic peptide containing a fusion peptide linked to a cytotoxic T lymphocyte epitope.
    Hsu SC; Shaw DM; Steward MW
    Immunology; 1995 Jul; 85(3):347-50. PubMed ID: 7558120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules.
    Newberg MH; Smith DH; Haertel SB; Vining DR; Lacy E; Engelhard VH
    J Immunol; 1996 Apr; 156(7):2473-80. PubMed ID: 8786307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
    Huang H; Li F; Gordon JR; Xiang J
    Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTL in mice immunized with human mucin 1 are MHC-restricted.
    Apostolopoulos V; Loveland BE; Pietersz GA; McKenzie IF
    J Immunol; 1995 Dec; 155(11):5089-94. PubMed ID: 7594517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.